Johnson & Johnson Medical Device Companies announces approach to reduce orthopedic care costs

The Johnson & Johnson Medical Devices Companies announced the Orthopaedic Episode Care Approach, which will be offered under its new CareAdvantage capabilities.

According to the release, the new approach was created to assist health systems and surgeons to decrease costs and improve orthopedic care and achieve value-based alternative care model goals, including the CMS’s Comprehensive Care for Joint Replacement and the Surgical Hip and Femur Fracture Treatment models. The Orthopaedic Episode of Care Approach will reportedly offer the Shared Performance Agreement to decrease costs for average episodic hip implants and knee implants.

“Reducing costs, enhancing patient outcomes and increasing patient satisfaction are core to our focus on helping health systems committed to delivering value-based care across a variety of therapeutic settings. In orthopaedics, where episode of care models are changing how reimbursement is aligned to performance, delivering on the Triple Aim is particularly important,” Tim Schmid, chief strategic customer officer, Johnson & Johnson Medical Devices Companies, said in the release.

He added, “Our Orthopaedic Episode of Care Approach builds on our breadth of experience in hip and knee replacements and hip fracture episodes of care, to help hospitals and surgeons realize better clinical and economic outcomes in these orthopaedic procedures. Providers now have an invested partner to help manage episodic costs and drive better, more predictable outcomes for patients.”

Reference: